During the past year, the FDA approved three new myeloma drugs! Please join us for a nursing-oriented, case-based, 1.5 CNE learning opportunity emphasizing nursing implications of new drugs and the latest myeloma research. Practical tool and clinical pearls will be interwoven with shared decision-making and collaborative practice considerations. RSVP today and join the International Myeloma Foundation's Nurse Leadership Board's exceptional nurse speakers for this exciting presentation.
This activity is supported by an educational grant from Amgen, Celgene Corporation, and Takeda Oncology.